NGS-based RNA-seq

World Market Report

MCP13599

EXECUTIVE ENGAGEMENTS

* Login for a full stack data experience

DATE

JAN 2022

TABLES

123

196

EDITION

9

PRICE

USD 5450

CODE

MCP13599

*Engagement stats are ongoing and dynamic

COMPETITIVE METRICS

COMPETITORS (ALPHABETICAL)	STRONG ACTIVE NICHE TRIVIAL % VALIDATED RESEARCH *
Agilent Technologies, Inc.	S A N T %
F. Hoffmann-La Roche AG	S A N T %
Illumina, Inc.	S A N T %
PerkinElmer, Inc.	S A N T %
Thermo Fisher Scientific, Inc.	S A N T %

* S = Strong; A = Active; N = Niche; T= Trivial (<1%)

* Login to Participate & View Data Stacks
* Participating executives must be from a competitive company. Executive credentials are validated by a one-time two-factor authentication, in compliance with GDPR guidelines. Verified executives have complimentary access to our proprietary MarketGlass^TM platform and relevant data silos including Trend Data; Brand/IP/TM Feeds; and Market Size, Share & Rank Clusters. Qualified influencers are also invited to join our Expert Panels. Privileges include purchase credits, and collaborative bespoke builds.

View All Companies...

PARTICIPATE NOW!

RESEARCH MODULES EXECUTIVES

HIGHLIGHTS & REPORT INDEX

Global NGS-based RNA-seq Market to Reach $4.4 Billion by 2026

Amid the COVID-19 crisis, the global market for NGS-based RNA-seq estimated at US$1.5 Billion in the year 2020, is projected to reach a revised size of US$4.4 Billion by 2026, growing at a CAGR of 19.9% over the analysis period. Sample Preparation, one of the segments analyzed in the report, is projected to record a 16% CAGR and reach US$998.2 Million by the end of the analysis period. After a thorough analysis of the business implications of the pandemic and its induced economic crisis, growth in the Sequencing Platforms & Consumables for RNA-Seq segment is readjusted to a revised 22.8% CAGR for the next 7-year period.

The U.S. Market is Estimated at $535.8 Million in 2021, While China is Forecast to Reach $777.3 Million by 2026

The NGS-based RNA-seq market in the U.S. is estimated at US$535.8 Million in the year 2021. China, the world`s second largest economy, is forecast to reach a projected market size of US$777.3 Million by the year 2026 trailing a CAGR of 19.3% over the analysis period. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 17.8% and 17.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 14.8% CAGR.

RNA Sequencing Services Segment to Reach US$1.1 Billion by the year 2026

In the global RNA Sequencing Services segment, USA, Canada, Japan, China and Europe will drive the 20% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$284 Million in the year 2020 will reach a projected size of US$1 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets.

SELECT PLAYERS

Agilent Technologies, Inc.; Eurofins Scientific; F. Hoffmann-La Roche AG; GATC Biotech AG; Illumina, Inc.; Macrogen, Inc.; Oxford Nanopore Technologies Ltd.; Pacific Biosciences of California, Inc.; PerkinElmer, Inc.; Qiagen NV; Thermo Fisher Scientific, Inc.

SEGMENTS

» Application (De Novo Transcriptome Assembly, Expression Profiling Analysis, Variant Calling and Transcriptome Epigenetics, Small RNA Sequencing) » End-Use (Research Centers & Academic & Government Institutes, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies, Other End-Uses) » Products & Services (Sample Preparation, Sequencing Platforms & Consumables for RNA-Seq, RNA Sequencing Services, Data Analysis, Storage, and Management) » Technology (Sequencing by Synthesis (SBS), Ion Semiconductor Sequencing, Single-molecule Real-time (SMRT) Sequencing, Nanopore Sequencing)

GEOGRAPHIES

» World » United States » Canada » Japan » China » Europe » France » Germany » Italy » United Kingdom » and Rest of Europe » Asia-Pacific » Rest of World

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

Influencer Market Insights

World Market Trajectories

RNA-Seq: An Introduction

A Prelude to NGS-based RNA-seq Market

North America: The Largest Market for NGS-based RNA-seq

Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

NGS-based RNA-seq Market Drivers and Restraints

Recent Advances in RNA Sequence Analysis

Select Players of NGS-based RNA-seq Market

Rise in Research Grants to Improve Activities in NGS-based RNA-Sequencing Technique

Application of RNA-Seq in Precision Medicine

Next Generation Sequencing in Cancer Research

Next Generation Sequencing for Transcriptomic Profiling

4. GLOBAL MARKET PERSPECTIVE

World Current & Future Analysis for NGS-based RNA-seq by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR

World 7-Year Perspective for NGS-based RNA-seq by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2020 & 2027

World Current & Future Analysis for Sample Preparation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR

World 7-Year Perspective for Sample Preparation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027

World Current & Future Analysis for Sequencing Platforms & Consumables for RNA-Seq by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR

World 7-Year Perspective for Sequencing Platforms & Consumables for RNA-Seq by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027

World Current & Future Analysis for RNA Sequencing Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR

World 7-Year Perspective for RNA Sequencing Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027

World Current & Future Analysis for Data Analysis, Storage, and Management by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR

World 7-Year Perspective for Data Analysis, Storage, and Management by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027

World Current & Future Analysis for Sequencing by Synthesis (SBS) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR

World 7-Year Perspective for Sequencing by Synthesis (SBS) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027

World Current & Future Analysis for Ion Semiconductor Sequencing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR

World 7-Year Perspective for Ion Semiconductor Sequencing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027

World Current & Future Analysis for Single-molecule Real-time (SMRT) Sequencing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR

World 7-Year Perspective for Single-molecule Real-time (SMRT) Sequencing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027

World Current & Future Analysis for Nanopore Sequencing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR

World 7-Year Perspective for Nanopore Sequencing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027

World Current & Future Analysis for De Novo Transcriptome Assembly by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR

World 7-Year Perspective for De Novo Transcriptome Assembly by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027

World Current & Future Analysis for Expression Profiling Analysis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR

World 7-Year Perspective for Expression Profiling Analysis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027

World Current & Future Analysis for Variant Calling and Transcriptome Epigenetics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR

World 7-Year Perspective for Variant Calling and Transcriptome Epigenetics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027

World Current & Future Analysis for Small RNA Sequencing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR

World 7-Year Perspective for Small RNA Sequencing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027

World Current & Future Analysis for Research Centers & Academic & Government Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR

World 7-Year Perspective for Research Centers & Academic & Government Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027

World Current & Future Analysis for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR

World 7-Year Perspective for Hospitals & Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027

World Current & Future Analysis for Pharmaceutical & Biotechnology Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR

World 7-Year Perspective for Pharmaceutical & Biotechnology Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027

World Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR

World 7-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027

III. MARKET ANALYSIS

UNITED STATES

USA Current & Future Analysis for NGS-based RNA-seq by Products & Services - Sample Preparation, Sequencing Platforms & Consumables for RNA-Seq, RNA Sequencing Services and Data Analysis, Storage, and Management - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR

USA 7-Year Perspective for NGS-based RNA-seq by Products & Services - Percentage Breakdown of Value Sales for Sample Preparation, Sequencing Platforms & Consumables for RNA-Seq, RNA Sequencing Services and Data Analysis, Storage, and Management for the Years 2020 & 2027

USA Current & Future Analysis for NGS-based RNA-seq by Technology - Sequencing by Synthesis (SBS), Ion Semiconductor Sequencing, Single-molecule Real-time (SMRT) Sequencing and Nanopore Sequencing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR

USA 7-Year Perspective for NGS-based RNA-seq by Technology - Percentage Breakdown of Value Sales for Sequencing by Synthesis (SBS), Ion Semiconductor Sequencing, Single-molecule Real-time (SMRT) Sequencing and Nanopore Sequencing for the Years 2020 & 2027

USA Current & Future Analysis for NGS-based RNA-seq by Application - De Novo Transcriptome Assembly, Expression Profiling Analysis, Variant Calling and Transcriptome Epigenetics and Small RNA Sequencing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR

USA 7-Year Perspective for NGS-based RNA-seq by Application - Percentage Breakdown of Value Sales for De Novo Transcriptome Assembly, Expression Profiling Analysis, Variant Calling and Transcriptome Epigenetics and Small RNA Sequencing for the Years 2020 & 2027

USA Current & Future Analysis for NGS-based RNA-seq by End-Use - Research Centers & Academic & Government Institutes, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR

USA 7-Year Perspective for NGS-based RNA-seq by End-Use - Percentage Breakdown of Value Sales for Research Centers & Academic & Government Institutes, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses for the Years 2020 & 2027

CANADA

Canada Current & Future Analysis for NGS-based RNA-seq by Products & Services - Sample Preparation, Sequencing Platforms & Consumables for RNA-Seq, RNA Sequencing Services and Data Analysis, Storage, and Management - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR

Canada 7-Year Perspective for NGS-based RNA-seq by Products & Services - Percentage Breakdown of Value Sales for Sample Preparation, Sequencing Platforms & Consumables for RNA-Seq, RNA Sequencing Services and Data Analysis, Storage, and Management for the Years 2020 & 2027

Canada Current & Future Analysis for NGS-based RNA-seq by Technology - Sequencing by Synthesis (SBS), Ion Semiconductor Sequencing, Single-molecule Real-time (SMRT) Sequencing and Nanopore Sequencing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR

Canada 7-Year Perspective for NGS-based RNA-seq by Technology - Percentage Breakdown of Value Sales for Sequencing by Synthesis (SBS), Ion Semiconductor Sequencing, Single-molecule Real-time (SMRT) Sequencing and Nanopore Sequencing for the Years 2020 & 2027

Canada Current & Future Analysis for NGS-based RNA-seq by Application - De Novo Transcriptome Assembly, Expression Profiling Analysis, Variant Calling and Transcriptome Epigenetics and Small RNA Sequencing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR

Canada 7-Year Perspective for NGS-based RNA-seq by Application - Percentage Breakdown of Value Sales for De Novo Transcriptome Assembly, Expression Profiling Analysis, Variant Calling and Transcriptome Epigenetics and Small RNA Sequencing for the Years 2020 & 2027

Canada Current & Future Analysis for NGS-based RNA-seq by End-Use - Research Centers & Academic & Government Institutes, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR

Canada 7-Year Perspective for NGS-based RNA-seq by End-Use - Percentage Breakdown of Value Sales for Research Centers & Academic & Government Institutes, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses for the Years 2020 & 2027

JAPAN

Japan Current & Future Analysis for NGS-based RNA-seq by Products & Services - Sample Preparation, Sequencing Platforms & Consumables for RNA-Seq, RNA Sequencing Services and Data Analysis, Storage, and Management - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR

Japan 7-Year Perspective for NGS-based RNA-seq by Products & Services - Percentage Breakdown of Value Sales for Sample Preparation, Sequencing Platforms & Consumables for RNA-Seq, RNA Sequencing Services and Data Analysis, Storage, and Management for the Years 2020 & 2027

Japan Current & Future Analysis for NGS-based RNA-seq by Technology - Sequencing by Synthesis (SBS), Ion Semiconductor Sequencing, Single-molecule Real-time (SMRT) Sequencing and Nanopore Sequencing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR

Japan 7-Year Perspective for NGS-based RNA-seq by Technology - Percentage Breakdown of Value Sales for Sequencing by Synthesis (SBS), Ion Semiconductor Sequencing, Single-molecule Real-time (SMRT) Sequencing and Nanopore Sequencing for the Years 2020 & 2027

Japan Current & Future Analysis for NGS-based RNA-seq by Application - De Novo Transcriptome Assembly, Expression Profiling Analysis, Variant Calling and Transcriptome Epigenetics and Small RNA Sequencing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR

Japan 7-Year Perspective for NGS-based RNA-seq by Application - Percentage Breakdown of Value Sales for De Novo Transcriptome Assembly, Expression Profiling Analysis, Variant Calling and Transcriptome Epigenetics and Small RNA Sequencing for the Years 2020 & 2027

Japan Current & Future Analysis for NGS-based RNA-seq by End-Use - Research Centers & Academic & Government Institutes, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR

Japan 7-Year Perspective for NGS-based RNA-seq by End-Use - Percentage Breakdown of Value Sales for Research Centers & Academic & Government Institutes, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses for the Years 2020 & 2027

CHINA

China Current & Future Analysis for NGS-based RNA-seq by Products & Services - Sample Preparation, Sequencing Platforms & Consumables for RNA-Seq, RNA Sequencing Services and Data Analysis, Storage, and Management - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR

China 7-Year Perspective for NGS-based RNA-seq by Products & Services - Percentage Breakdown of Value Sales for Sample Preparation, Sequencing Platforms & Consumables for RNA-Seq, RNA Sequencing Services and Data Analysis, Storage, and Management for the Years 2020 & 2027

China Current & Future Analysis for NGS-based RNA-seq by Technology - Sequencing by Synthesis (SBS), Ion Semiconductor Sequencing, Single-molecule Real-time (SMRT) Sequencing and Nanopore Sequencing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR

China 7-Year Perspective for NGS-based RNA-seq by Technology - Percentage Breakdown of Value Sales for Sequencing by Synthesis (SBS), Ion Semiconductor Sequencing, Single-molecule Real-time (SMRT) Sequencing and Nanopore Sequencing for the Years 2020 & 2027

China Current & Future Analysis for NGS-based RNA-seq by Application - De Novo Transcriptome Assembly, Expression Profiling Analysis, Variant Calling and Transcriptome Epigenetics and Small RNA Sequencing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR

China 7-Year Perspective for NGS-based RNA-seq by Application - Percentage Breakdown of Value Sales for De Novo Transcriptome Assembly, Expression Profiling Analysis, Variant Calling and Transcriptome Epigenetics and Small RNA Sequencing for the Years 2020 & 2027

China Current & Future Analysis for NGS-based RNA-seq by End-Use - Research Centers & Academic & Government Institutes, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR

China 7-Year Perspective for NGS-based RNA-seq by End-Use - Percentage Breakdown of Value Sales for Research Centers & Academic & Government Institutes, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses for the Years 2020 & 2027

EUROPE

Europe Current & Future Analysis for NGS-based RNA-seq by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR

Europe 7-Year Perspective for NGS-based RNA-seq by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2020 & 2027

Europe Current & Future Analysis for NGS-based RNA-seq by Products & Services - Sample Preparation, Sequencing Platforms & Consumables for RNA-Seq, RNA Sequencing Services and Data Analysis, Storage, and Management - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR

Europe 7-Year Perspective for NGS-based RNA-seq by Products & Services - Percentage Breakdown of Value Sales for Sample Preparation, Sequencing Platforms & Consumables for RNA-Seq, RNA Sequencing Services and Data Analysis, Storage, and Management for the Years 2020 & 2027

Europe Current & Future Analysis for NGS-based RNA-seq by Technology - Sequencing by Synthesis (SBS), Ion Semiconductor Sequencing, Single-molecule Real-time (SMRT) Sequencing and Nanopore Sequencing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR

Europe 7-Year Perspective for NGS-based RNA-seq by Technology - Percentage Breakdown of Value Sales for Sequencing by Synthesis (SBS), Ion Semiconductor Sequencing, Single-molecule Real-time (SMRT) Sequencing and Nanopore Sequencing for the Years 2020 & 2027

Europe Current & Future Analysis for NGS-based RNA-seq by Application - De Novo Transcriptome Assembly, Expression Profiling Analysis, Variant Calling and Transcriptome Epigenetics and Small RNA Sequencing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR

Europe 7-Year Perspective for NGS-based RNA-seq by Application - Percentage Breakdown of Value Sales for De Novo Transcriptome Assembly, Expression Profiling Analysis, Variant Calling and Transcriptome Epigenetics and Small RNA Sequencing for the Years 2020 & 2027

Europe Current & Future Analysis for NGS-based RNA-seq by End-Use - Research Centers & Academic & Government Institutes, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR

Europe 7-Year Perspective for NGS-based RNA-seq by End-Use - Percentage Breakdown of Value Sales for Research Centers & Academic & Government Institutes, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses for the Years 2020 & 2027

FRANCE

France Current & Future Analysis for NGS-based RNA-seq by Products & Services - Sample Preparation, Sequencing Platforms & Consumables for RNA-Seq, RNA Sequencing Services and Data Analysis, Storage, and Management - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR

France 7-Year Perspective for NGS-based RNA-seq by Products & Services - Percentage Breakdown of Value Sales for Sample Preparation, Sequencing Platforms & Consumables for RNA-Seq, RNA Sequencing Services and Data Analysis, Storage, and Management for the Years 2020 & 2027

France Current & Future Analysis for NGS-based RNA-seq by Technology - Sequencing by Synthesis (SBS), Ion Semiconductor Sequencing, Single-molecule Real-time (SMRT) Sequencing and Nanopore Sequencing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR

France 7-Year Perspective for NGS-based RNA-seq by Technology - Percentage Breakdown of Value Sales for Sequencing by Synthesis (SBS), Ion Semiconductor Sequencing, Single-molecule Real-time (SMRT) Sequencing and Nanopore Sequencing for the Years 2020 & 2027

France Current & Future Analysis for NGS-based RNA-seq by Application - De Novo Transcriptome Assembly, Expression Profiling Analysis, Variant Calling and Transcriptome Epigenetics and Small RNA Sequencing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR

France 7-Year Perspective for NGS-based RNA-seq by Application - Percentage Breakdown of Value Sales for De Novo Transcriptome Assembly, Expression Profiling Analysis, Variant Calling and Transcriptome Epigenetics and Small RNA Sequencing for the Years 2020 & 2027

France Current & Future Analysis for NGS-based RNA-seq by End-Use - Research Centers & Academic & Government Institutes, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR

France 7-Year Perspective for NGS-based RNA-seq by End-Use - Percentage Breakdown of Value Sales for Research Centers & Academic & Government Institutes, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses for the Years 2020 & 2027

GERMANY

Germany Current & Future Analysis for NGS-based RNA-seq by Products & Services - Sample Preparation, Sequencing Platforms & Consumables for RNA-Seq, RNA Sequencing Services and Data Analysis, Storage, and Management - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR

Germany 7-Year Perspective for NGS-based RNA-seq by Products & Services - Percentage Breakdown of Value Sales for Sample Preparation, Sequencing Platforms & Consumables for RNA-Seq, RNA Sequencing Services and Data Analysis, Storage, and Management for the Years 2020 & 2027

Germany Current & Future Analysis for NGS-based RNA-seq by Technology - Sequencing by Synthesis (SBS), Ion Semiconductor Sequencing, Single-molecule Real-time (SMRT) Sequencing and Nanopore Sequencing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR

Germany 7-Year Perspective for NGS-based RNA-seq by Technology - Percentage Breakdown of Value Sales for Sequencing by Synthesis (SBS), Ion Semiconductor Sequencing, Single-molecule Real-time (SMRT) Sequencing and Nanopore Sequencing for the Years 2020 & 2027

Germany Current & Future Analysis for NGS-based RNA-seq by Application - De Novo Transcriptome Assembly, Expression Profiling Analysis, Variant Calling and Transcriptome Epigenetics and Small RNA Sequencing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR

Germany 7-Year Perspective for NGS-based RNA-seq by Application - Percentage Breakdown of Value Sales for De Novo Transcriptome Assembly, Expression Profiling Analysis, Variant Calling and Transcriptome Epigenetics and Small RNA Sequencing for the Years 2020 & 2027

Germany Current & Future Analysis for NGS-based RNA-seq by End-Use - Research Centers & Academic & Government Institutes, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR

Germany 7-Year Perspective for NGS-based RNA-seq by End-Use - Percentage Breakdown of Value Sales for Research Centers & Academic & Government Institutes, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses for the Years 2020 & 2027

ITALY

Italy Current & Future Analysis for NGS-based RNA-seq by Products & Services - Sample Preparation, Sequencing Platforms & Consumables for RNA-Seq, RNA Sequencing Services and Data Analysis, Storage, and Management - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR

Italy 7-Year Perspective for NGS-based RNA-seq by Products & Services - Percentage Breakdown of Value Sales for Sample Preparation, Sequencing Platforms & Consumables for RNA-Seq, RNA Sequencing Services and Data Analysis, Storage, and Management for the Years 2020 & 2027

Italy Current & Future Analysis for NGS-based RNA-seq by Technology - Sequencing by Synthesis (SBS), Ion Semiconductor Sequencing, Single-molecule Real-time (SMRT) Sequencing and Nanopore Sequencing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR

Italy 7-Year Perspective for NGS-based RNA-seq by Technology - Percentage Breakdown of Value Sales for Sequencing by Synthesis (SBS), Ion Semiconductor Sequencing, Single-molecule Real-time (SMRT) Sequencing and Nanopore Sequencing for the Years 2020 & 2027

Italy Current & Future Analysis for NGS-based RNA-seq by Application - De Novo Transcriptome Assembly, Expression Profiling Analysis, Variant Calling and Transcriptome Epigenetics and Small RNA Sequencing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR

Italy 7-Year Perspective for NGS-based RNA-seq by Application - Percentage Breakdown of Value Sales for De Novo Transcriptome Assembly, Expression Profiling Analysis, Variant Calling and Transcriptome Epigenetics and Small RNA Sequencing for the Years 2020 & 2027

Italy Current & Future Analysis for NGS-based RNA-seq by End-Use - Research Centers & Academic & Government Institutes, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR

Italy 7-Year Perspective for NGS-based RNA-seq by End-Use - Percentage Breakdown of Value Sales for Research Centers & Academic & Government Institutes, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses for the Years 2020 & 2027

UNITED KINGDOM

UK Current & Future Analysis for NGS-based RNA-seq by Products & Services - Sample Preparation, Sequencing Platforms & Consumables for RNA-Seq, RNA Sequencing Services and Data Analysis, Storage, and Management - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR

UK 7-Year Perspective for NGS-based RNA-seq by Products & Services - Percentage Breakdown of Value Sales for Sample Preparation, Sequencing Platforms & Consumables for RNA-Seq, RNA Sequencing Services and Data Analysis, Storage, and Management for the Years 2020 & 2027

UK Current & Future Analysis for NGS-based RNA-seq by Technology - Sequencing by Synthesis (SBS), Ion Semiconductor Sequencing, Single-molecule Real-time (SMRT) Sequencing and Nanopore Sequencing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR

UK 7-Year Perspective for NGS-based RNA-seq by Technology - Percentage Breakdown of Value Sales for Sequencing by Synthesis (SBS), Ion Semiconductor Sequencing, Single-molecule Real-time (SMRT) Sequencing and Nanopore Sequencing for the Years 2020 & 2027

UK Current & Future Analysis for NGS-based RNA-seq by Application - De Novo Transcriptome Assembly, Expression Profiling Analysis, Variant Calling and Transcriptome Epigenetics and Small RNA Sequencing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR

UK 7-Year Perspective for NGS-based RNA-seq by Application - Percentage Breakdown of Value Sales for De Novo Transcriptome Assembly, Expression Profiling Analysis, Variant Calling and Transcriptome Epigenetics and Small RNA Sequencing for the Years 2020 & 2027

UK Current & Future Analysis for NGS-based RNA-seq by End-Use - Research Centers & Academic & Government Institutes, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR

UK 7-Year Perspective for NGS-based RNA-seq by End-Use - Percentage Breakdown of Value Sales for Research Centers & Academic & Government Institutes, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses for the Years 2020 & 2027

REST OF EUROPE

Rest of Europe Current & Future Analysis for NGS-based RNA-seq by Products & Services - Sample Preparation, Sequencing Platforms & Consumables for RNA-Seq, RNA Sequencing Services and Data Analysis, Storage, and Management - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR

Rest of Europe 7-Year Perspective for NGS-based RNA-seq by Products & Services - Percentage Breakdown of Value Sales for Sample Preparation, Sequencing Platforms & Consumables for RNA-Seq, RNA Sequencing Services and Data Analysis, Storage, and Management for the Years 2020 & 2027

Rest of Europe Current & Future Analysis for NGS-based RNA-seq by Technology - Sequencing by Synthesis (SBS), Ion Semiconductor Sequencing, Single-molecule Real-time (SMRT) Sequencing and Nanopore Sequencing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR

Rest of Europe 7-Year Perspective for NGS-based RNA-seq by Technology - Percentage Breakdown of Value Sales for Sequencing by Synthesis (SBS), Ion Semiconductor Sequencing, Single-molecule Real-time (SMRT) Sequencing and Nanopore Sequencing for the Years 2020 & 2027

Rest of Europe Current & Future Analysis for NGS-based RNA-seq by Application - De Novo Transcriptome Assembly, Expression Profiling Analysis, Variant Calling and Transcriptome Epigenetics and Small RNA Sequencing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR

Rest of Europe 7-Year Perspective for NGS-based RNA-seq by Application - Percentage Breakdown of Value Sales for De Novo Transcriptome Assembly, Expression Profiling Analysis, Variant Calling and Transcriptome Epigenetics and Small RNA Sequencing for the Years 2020 & 2027

Rest of Europe Current & Future Analysis for NGS-based RNA-seq by End-Use - Research Centers & Academic & Government Institutes, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR

Rest of Europe 7-Year Perspective for NGS-based RNA-seq by End-Use - Percentage Breakdown of Value Sales for Research Centers & Academic & Government Institutes, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses for the Years 2020 & 2027

ASIA-PACIFIC

Asia-Pacific Current & Future Analysis for NGS-based RNA-seq by Products & Services - Sample Preparation, Sequencing Platforms & Consumables for RNA-Seq, RNA Sequencing Services and Data Analysis, Storage, and Management - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR

Asia-Pacific 7-Year Perspective for NGS-based RNA-seq by Products & Services - Percentage Breakdown of Value Sales for Sample Preparation, Sequencing Platforms & Consumables for RNA-Seq, RNA Sequencing Services and Data Analysis, Storage, and Management for the Years 2020 & 2027

Asia-Pacific Current & Future Analysis for NGS-based RNA-seq by Technology - Sequencing by Synthesis (SBS), Ion Semiconductor Sequencing, Single-molecule Real-time (SMRT) Sequencing and Nanopore Sequencing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR

Asia-Pacific 7-Year Perspective for NGS-based RNA-seq by Technology - Percentage Breakdown of Value Sales for Sequencing by Synthesis (SBS), Ion Semiconductor Sequencing, Single-molecule Real-time (SMRT) Sequencing and Nanopore Sequencing for the Years 2020 & 2027

Asia-Pacific Current & Future Analysis for NGS-based RNA-seq by Application - De Novo Transcriptome Assembly, Expression Profiling Analysis, Variant Calling and Transcriptome Epigenetics and Small RNA Sequencing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR

Asia-Pacific 7-Year Perspective for NGS-based RNA-seq by Application - Percentage Breakdown of Value Sales for De Novo Transcriptome Assembly, Expression Profiling Analysis, Variant Calling and Transcriptome Epigenetics and Small RNA Sequencing for the Years 2020 & 2027

Asia-Pacific Current & Future Analysis for NGS-based RNA-seq by End-Use - Research Centers & Academic & Government Institutes, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR

Asia-Pacific 7-Year Perspective for NGS-based RNA-seq by End-Use - Percentage Breakdown of Value Sales for Research Centers & Academic & Government Institutes, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses for the Years 2020 & 2027

REST OF WORLD

Rest of World Current & Future Analysis for NGS-based RNA-seq by Products & Services - Sample Preparation, Sequencing Platforms & Consumables for RNA-Seq, RNA Sequencing Services and Data Analysis, Storage, and Management - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR

Rest of World 7-Year Perspective for NGS-based RNA-seq by Products & Services - Percentage Breakdown of Value Sales for Sample Preparation, Sequencing Platforms & Consumables for RNA-Seq, RNA Sequencing Services and Data Analysis, Storage, and Management for the Years 2020 & 2027

Rest of World Current & Future Analysis for NGS-based RNA-seq by Technology - Sequencing by Synthesis (SBS), Ion Semiconductor Sequencing, Single-molecule Real-time (SMRT) Sequencing and Nanopore Sequencing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR

Rest of World 7-Year Perspective for NGS-based RNA-seq by Technology - Percentage Breakdown of Value Sales for Sequencing by Synthesis (SBS), Ion Semiconductor Sequencing, Single-molecule Real-time (SMRT) Sequencing and Nanopore Sequencing for the Years 2020 & 2027

Rest of World Current & Future Analysis for NGS-based RNA-seq by Application - De Novo Transcriptome Assembly, Expression Profiling Analysis, Variant Calling and Transcriptome Epigenetics and Small RNA Sequencing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR

Rest of World 7-Year Perspective for NGS-based RNA-seq by Application - Percentage Breakdown of Value Sales for De Novo Transcriptome Assembly, Expression Profiling Analysis, Variant Calling and Transcriptome Epigenetics and Small RNA Sequencing for the Years 2020 & 2027

Rest of World Current & Future Analysis for NGS-based RNA-seq by End-Use - Research Centers & Academic & Government Institutes, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR

Rest of World 7-Year Perspective for NGS-based RNA-seq by End-Use - Percentage Breakdown of Value Sales for Research Centers & Academic & Government Institutes, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses for the Years 2020 & 2027

IV. COMPETITION

Total Companies Profiled: 46

PREVIEW REPORT

YOUR PRIVACY MATTERS!

Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.

What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com

DIFFERENTIATORS

Integrity Trust Transparency

Our research offerings primarily draw upon unique perspectives of participating executives and their experiences in operating and strategy roles. These geo-focused insights enrich our projects .

What we are NOT - Our reports are not editorial exercises of remote analysts’ secondary source fed content that predominantly flood today’s off-the-shelf market report business. (A review of 262 publishers).

WHAT SETS US APART

FULL STACK DATA ACCESS

Primary Research Cluster Data
Influencer Engagement Stats
Evidence of Primary Research
List of Companies Engaged
Hundreds of Pages of Research
Peer Collaborative Interactions
Enterprise Data Exchanges
MarketGlassTM Platform Insider
Geographic Pricing Dynamics
Competitive Shares by Country
Brand Curation & Insights
Domain Expert Pool

Program Transparency: Clients have access to engagement stats of companies and executives. Clients may commission third-party audits of our influencer engagements at their expense.

Primary Research: We have a very successful incentive driven primary research program presenting a rich experience to participating executives. Featured company executives can sign up for a complimentary.

Collaborative Intelligence: Our platform presents a unique features for executives to collaborate with peers across geographies and participate on various product or regional perspectives for a collective unified insider project experience.

Global Brand Intelligence: We present competitive brand intelligence at the company level for players worldwide. Executives from brand owner companies participate to curate each brand for relevance and market presence.

Bespoke Updates: Our peer-to-peer online interactive platform enables client companies to build upon our project data stacks to build bespoke editions for internal sharing and use. Client company can build one complimentary update per year and unlimited updates for additional fee. Bespoke updates are fulfilled within a two-day turnaround.

Enterprise EcoConnect: Discretely bounce off queries to participant pool of executives. We can reach out to our participant pool based on specifics of geographic or domain acumen.

Renowned Support: We pride in our commitment to provide support to our clients. We go beyond the scope of the study to get you timely answers.

Complimentary Updates: Unlike the industry’s published PDF’s that are frozen in time from date of release, our research programs are ongoing and dynamic. Our reports are updated whenever there’s a major event impacting the marketplace. Your license offers seamless updates for one year.

No Fluff: We offer our clients the best CX with clean easy to read content. No verbose fluff. We offer clients full access to the entire stack of hundreds of pages of secondary research feeds used in our project via our online MarketGlass portal.

NGS-based RNA-seq

World Market Report

MCP13599

EXECUTIVE ENGAGEMENTS

POOL

INTERACTIONS

PARTICIPANTS

VALIDATIONS

COMPANIES

* Login for a full stack data experience

DATE

JAN 2022

TABLES

123

PAGES

196

EDITION

9

PRICE

USD 5450

CODE

MCP13599

COMPETITIVE METRICS

COMPETITORS (ALPHABETICAL)

%

VALIDATED RESEARCH *

Agilent Technologies, Inc.

F. Hoffmann-La Roche AG

Illumina, Inc.

PerkinElmer, Inc.

Thermo Fisher Scientific, Inc.

OUR EXPERT PANELS

Panelists are carefully chosen based on their domain expertise and market influence.

INFLUENCER INVITEE

WHY PARTICIPATE?

Expertise to the Power of YOU!

GLOBAL EXPERT PANEL

HIGHLIGHTS & REPORT INDEX

SELECT PLAYERS

SEGMENTS

GEOGRAPHIES

TABLE OF CONTENTS

PREVIEW REPORT

DIFFERENTIATORS

WHAT SETS US APART

FULL STACK DATA ACCESS